The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011–2012)
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011–2012)
Authors
Keywords
-
Journal
Open Forum Infectious Diseases
Volume 4, Issue 2, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-05-02
DOI
10.1093/ofid/ofx089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PandemicH30 Subclone ofEscherichia coliSequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts
- (2016) James R. Johnson et al. CLINICAL INFECTIOUS DISEASES
- Population structure ofEscherichia colicausing bacteraemia in the UK and Ireland between 2001 and 2010
- (2016) M. J. Day et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Siderophore vaccine conjugates protect against uropathogenicEscherichia coliurinary tract infection
- (2016) Laura A. Mike et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models
- (2016) Germie P.J.M. van den Dobbelsteen et al. VACCINE
- Household Clustering ofEscherichia coliSequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis
- (2016) James R. Johnson et al. Open Forum Infectious Diseases
- Variation in Resistance Traits, Phylogenetic Backgrounds, and Virulence Genotypes among Escherichia coli Clinical Isolates from Adjacent Hospital Campuses Serving Distinct Patient Populations
- (2015) Sarah M. Drawz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characteristics of Escherichia coli Sequence Type 131 Isolates That Produce Extended-Spectrum β-Lactamases: Global Distribution of theH30-Rx Sublineage
- (2014) Gisele Peirano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Escherichia coli ST131, an Intriguing Clonal Group
- (2014) M.-H. Nicolas-Chanoine et al. CLINICAL MICROBIOLOGY REVIEWS
- Large-scale genomic sequencing of extraintestinal pathogenicEscherichia colistrains
- (2014) Stephen J. Salipante et al. GENOME RESEARCH
- Rapid and Specific Detection, Molecular Epidemiology, and Experimental Virulence of the O16 Subgroup within Escherichia coli Sequence Type 131
- (2014) J. R. Johnson et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Development of an allele-specific PCR for Escherichia coli B2 sub-typing, a rapid and easy to perform substitute of multilocus sequence typing
- (2014) Olivier Clermont et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Global dissemination of a multidrug resistant Escherichia coli clone
- (2014) N. K. Petty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)
- (2013) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010
- (2013) Ritu Banerjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans
- (2013) Aylin Colpan et al. CLINICAL INFECTIOUS DISEASES
- Predictors and Molecular Epidemiology of Community-Onset Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in a Midwestern Community
- (2013) Ritu Banerjee et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
- (2013) James R. Johnson et al. JOURNAL OF INFECTIOUS DISEASES
- Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) andblaCTX-M-15among Extended-Spectrum-β-Lactamase-Producing E. coli from the United States, 2000 to 2009
- (2012) James R. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Virulence of Escherichia coli Clinical Isolates in a Murine Sepsis Model in Relation to Sequence Type ST131 Status, Fluoroquinolone Resistance, and Virulence Genotype
- (2012) James R. Johnson et al. INFECTION AND IMMUNITY
- Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum- -lactamase-producing Escherichia coli in Japan
- (2012) Y. Matsumura et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The ClermontEscherichia coliphylo-typing method revisited: improvement of specificity and detection of new phylo-groups
- (2012) Olivier Clermont et al. Environmental Microbiology Reports
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
- (2011) Kalpana Gupta et al. CLINICAL INFECTIOUS DISEASES
- Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States
- (2010) James R. Johnson et al. CLINICAL INFECTIOUS DISEASES
- Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004
- (2009) J. R. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started